Hemorrhagic complications in premature infants treated with intravitreal bevacizumab. Ozbay EK, Sabanci S, Kucuk MF, Erol MK, et al. Int Ophthalmol 2025;45:254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozbay EK, Sabanci S, Kucuk MF, Erol MK, et al. Hemorrhagic complications in premature infants treated with intravitreal bevacizumab. Int Ophthalmol 2025;45:254.
PMID: 40540050